American Society of Hospital Pharmacists'Midyear clinical meeting. Miami Beach FL USA, 1994/12.
This study investigated the cost of propofol versus thiopental anesthesia in 243 patients who underwent outpatient laparoscopic gynecologic surgery.
Patient records were analyzed for medication use, duration of surgery, anesthesia, recovery room stay, and associated costs.
Despite the higher drug cost for propofol, the total mean cost was $273.00 less per patient for patients receiving propofol induction anesthesia.
Extension of these data translates into cost savings of approximately $7900.00 if propofol had been used for all patients.
Although the duration of surgery for the propofol group was shorter by nearly 12 minutes, the anesthesia duration and recovery room stay were both longer for the thiopental group, reflecting the longer duration of action of thiopental.
Although the realized cost savings of drugs, surgery, anesthesia, and recovery time when propofol versus thiopental is used for outpatient laparoscopic gynecologic surgery are relatively small on an individual patient basis, cost savings may become more significant if larger patient populations are studied.
Mots-clés Pascal : Coût financement, Propofol, Thiopental sodique, Gynécologie, Analyse coût, Ambulatoire, Homme, Anesthésie générale, Anesthésique général, Induction, Laparoscopie, Chirurgie, Appareil génital femelle, Economie santé
Mots-clés Pascal anglais : Financing cost, Gynecology, Cost analysis, Ambulatory, Human, General anesthesia, General anesthetic, Induction, Laparoscopy, Surgery, Female genital system, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0575820
Code Inist : 002B30A04B. Création : 01/03/1996.